iRadimed Balance Sheet
NASDAQ: IRMDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
iRadimed financial position
At the end of fiscal 2025, iRadimed reported total assets of $108.8 million, up 10.6% from a year earlier against total liabilities of $14.2 million. Shareholders' equity stood at $94.6 million, or 87.0% of assets. The company held $51.2 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 7.98, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
iRadimed balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 51.16M | 52.23M | 49.76M | 57.96M | 62.00M | 50.07M | 43.48M | 28.03M | 18.21M | 17.71M |
| Short-Term Investments | — | — | — | — | — | — | — | — | 8.14M | 7.97M |
| Receivables | 13.67M | 10.56M | 12.22M | 13.27M | 5.14M | 4.57M | 7.29M | 4.21M | 3.78M | 3.78M |
| Inventory | 11.62M | 10.40M | 12.82M | 5.37M | 4.30M | 3.93M | 3.64M | 4.06M | 4.21M | 3.89M |
| Total Current Assets | 81.20M | 75.24M | 76.00M | 77.49M | 76.24M | 63.74M | 58.96M | 44.54M | 35.11M | 33.86M |
| Property, Plant & Equipment | 23.86M | 16.81M | 9.29M | 2.40M | 2.07M | 2.12M | 2.05M | 1.87M | 1.87M | 1.46M |
| Intangible Assets | 3.38M | 3.10M | 2.52M | 2.07M | 1.12M | 960.88K | 860.09K | 832.52K | 885.50K | 918.71K |
| Total Assets | 108.78M | 98.33M | 92.16M | 85.51M | 82.88M | 71.07M | 66.73M | 48.44M | 39.01M | 37.19M |
| Accounts Payable | 1.82M | 1.90M | 1.86M | 1.80M | 782.90K | 657.05K | 993.74K | 772.47K | 656.72K | 1.12M |
| Total Current Liabilities | 10.18M | 8.51M | 16.33M | 8.55M | 6.82M | 4.92M | 5.86M | 4.69M | 4.08M | 3.66M |
| Total Liabilities | 14.16M | 11.51M | 20.74M | 11.84M | 10.71M | 9.68M | 11.20M | 6.50M | 6.08M | 5.31M |
| Shareholders' Equity | 94.62M | 86.82M | 71.42M | 73.67M | 72.17M | 61.38M | 55.52M | 41.95M | 32.93M | 31.89M |
| Retained Earnings | 64.23M | 56.79M | 43.26M | 47.26M | 46.99M | 37.67M | 36.30M | 26.67M | 20.36M | 19.87M |
| Net Cash (Debt) | 51.16M | 52.23M | 49.76M | 57.96M | 62.00M | 50.07M | 43.48M | 28.03M | 26.34M | 25.68M |
| Shares Outstanding | 12.78M | 12.71M | 12.66M | 12.59M | 12.54M | 12.31M | 11.77M | 10.99M | 10.60M | 10.72M |
This table shows 10 annual periods of iRadimed's balance sheet, from FY 2025 back to FY 2016, across 15 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow IRMD's reporting calendar. What is a balance sheet?